"Overall, this is very good news for the vaccination program, both in regards to the supply of vaccine as well as to its potential efficacy," Fauci said.
The pediatric trial includes children 6 months to 17 years old and is testing responses to two doses of vaccine -- 15 micrograms and 30 micrograms, Fauci said. The vaccine is made by Sanofi Pasteur in Swiftwater, Pa.
U.S. health officials reported earlier that adults would need only one dose of the H1N1 flu vaccine.
On Friday, U.S. health officials said the first doses of the H1N1 swine flu vaccine will start shipping the first week in October, which is slightly earlier than expected. These first 3.4 million doses will come in the form of the nasal spray FluMist.
But FluMist is not recommended for children under 2 years of age; people with chronic medical conditions such as heart disease, kidney disease and diabetes; pregnant women; or people older than 49. Children, pregnant women, and people with chronic health conditions -- such as asthma, diabetes and heart disease -- are among those at greatest risk for complications from the H1N1 swine flu, according to the U.S. Centers for Disease Control and Prevention.
There may also be some injectable H1N1 flu vaccine available in early October, but how much is not known yet, officials said.
At a press briefing on Friday, Dr. Daniel Jernigan, deputy director of the Influenza Division at the CDC, said the H1N1 virus, though widespread, continues to produce mild illness in most people and recovery time is fairly quick.
Jernigan said it's important to get an H1N1 flu shot when the vaccine becomes available. People should also get a seasonal flu shot -- which is available now -- because the seasonal flu will start t
All rights reserved